Application of biosensors for diagnosis and treatment of disease
January 16, 2023. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod of diagnosing periodontal disease through the detection of pyridine compounds Method of detecting Pseudomonas aeruginosa infections utilizing selected ketone and/or sulfur metabolites Detection of lung cancer using breath luminescence Method of detecting the presence of bronchogenic carcinoma by analysis of expired lung air Method and device for the production of carbon nanotubes Real time chemical exposure and risk monitor Flow cell SELEX Breath test for detection of lung cancer Disease diagnosis by vapor sample analysis Method for making nanotubes and nanoparticles InventorsAssigneeApplicationNo. 10345532 filed on 01/16/2003US Classes:436/518, INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS422/84, Breath tester435/6, Involving nucleic acid435/7.1, Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay435/7.9, Assay in which an enzyme present is a label435/7.92, Heterogeneous or solid phase assay system (e.g., ELISA, etc.)436/164, OPTICAL RESULT436/172, With fluorescence or luminescence436/524, Carrier is inorganic436/528, Carrier is organic436/805, OPTICAL PROPERTY436/811, TEST FOR NAMED DISEASE, BODY CONDITION OR ORGAN FUNCTION436/815, TEST FOR NAMED COMPOUND OR CLASS OF COMPOUNDS436/900, BREATH TESTING422/91, With photometric detector435/25, Involving oxidoreductase436/151, By means of a solid body in contact with a fluid600/532, Qualitative or quantitative analysis of breath component424/9.2Testing efficacy or toxicity of a compound or composition (e.g., drug, vaccine, etc.)ExaminersPrimary: Chin, Christopher L.Attorney, Agent or FirmForeign Patent References
International ClassG01N033/543AbstractA method for detecting compounds of interest in bodily fluids, including exhaled breath and blood. The present invention uses biosensors that mimic naturally occurring cellular mechanisms, including RNA oligonucleotide chains or “aptamers,” in combination with molecular beacons or nanotechnology to provide an effective and efficient method for diagnosing a condition and/or disease within a patient. The subject invention also provides a method for screening those analytes/biomarkers likely to be present in exhaled breath.Other References
Field of SearchOPTICAL RESULTWith fluorescence or luminescence INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS Carrier is inorganic Carrier is organic OPTICAL PROPERTY TEST FOR NAMED DISEASE, BODY CONDITION OR ORGAN FUNCTION TEST FOR NAMED COMPOUND OR CLASS OF COMPOUNDS BREATH TESTING MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay Assay in which an enzyme present is a label Heterogeneous or solid phase assay system (e.g., ELISA, etc.) Involving nucleic acid Means for analyzing gas sample Breath tester Based on color change Including means reacting gas with color indicator |
| ||||||||||||||
